BioCentury
ARTICLE | Company News

FDA approves Integrilin dosing regimen

June 11, 2001 7:00 AM UTC

Cor (CORR) and partner Schering-Plough (SGP) said the FDA approved revised prescribing information for Integrilin to include a new dosing regimen for patients undergoing percutaneous coronary interven...